Spectroscopyand Neck Cancer by Magnetic Resonance Prediction of Treatment Response in Head

,

[1]  Group I , 2005, Babylonian Planetary Omens: Part Four.

[2]  D. Yeung,et al.  In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. , 2004, AJNR. American journal of neuroradiology.

[3]  N. Fischbein,et al.  Newer MR imaging techniques for head and neck. , 2003, Magnetic resonance imaging clinics of North America.

[4]  George Fountzilas,et al.  Usefulness of Tumor Volumetry as a Prognostic Factor of Survival in Head and Neck Cancer , 2003, Strahlentherapie und Onkologie.

[5]  F. Howe,et al.  Magnetic Resonance Spectroscopy of cancer-practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma. , 2002, European journal of cancer.

[6]  Rakesh Patel,et al.  Statistical Classification Strategy for Proton Magnetic Resonance Spectra of Soft Tissue Sarcoma: An Exploratory Study with Potential Clinical Utility , 2002, Sarcoma.

[7]  R. Somorjai,et al.  An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region , 2002, Head & neck.

[8]  Mark Rijpkema,et al.  Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. , 2002, Academic radiology.

[9]  J. Walecki,et al.  1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. , 2002, International journal of radiation oncology, biology, physics.

[10]  C E Mountford,et al.  Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine‐needle aspirates analysed using a statistical classification strategy , 2001, The British journal of surgery.

[11]  R L Somorjai,et al.  Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity. , 2001, International journal of radiation oncology, biology, physics.

[12]  M. Castillo,et al.  The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. , 2000, AJNR. American journal of neuroradiology.

[13]  R J Gerstle,et al.  The role of neural networks in improving the accuracy of MR spectroscopy for the diagnosis of head and neck squamous cell carcinoma. , 2000, AJNR. American journal of neuroradiology.

[14]  R. Gillies,et al.  Nm23‐transfected MDA‐mB‐435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A 31P nuclear magnetic resonance study in vivo and in vitro , 1999, Magnetic resonance in medicine.

[15]  L. N. Gías,et al.  Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base , 1998 .

[16]  Susan M. Chang,et al.  Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. , 1997, Journal of neurosurgery.

[17]  N. Lundbom,et al.  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997, Journal of Neurosurgery.

[18]  R. Somorjai,et al.  Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.

[19]  W. Mackinnon,et al.  Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. , 1997, Radiology.

[20]  R L Somorjai,et al.  The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. , 1997, Cancer research.

[21]  K. Muller,et al.  Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. , 1997, AJNR. American journal of neuroradiology.

[22]  M. Castillo,et al.  Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. , 1996, AJNR. American journal of neuroradiology.

[23]  J. Wennerberg.  Predicting response to therapy of squamous cell carcinoma of the head and neck (review). , 1996, Anticancer research.

[24]  M O Leach,et al.  Introduction to in vivo MRS of cancer: new perspectives and open problems. , 1996, Anticancer research.

[25]  B. Têtu,et al.  p53 overexpression in head and neck squamous cell carcinoma: review of the literature. , 1996, European journal of cancer. Part B, Oral oncology.

[26]  R. Somorjai,et al.  Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. , 1996, Anticancer research.

[27]  L. Barnes,et al.  Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral cavity and oropharynx , 1995, The Laryngoscope.

[28]  Peter Russell,et al.  Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms , 1995, Magnetic resonance in medicine.

[29]  A. Okada,et al.  Increased aspartate and glutamate levels in both gastric and colon cancer tissues. , 1993, The Tokushima journal of experimental medicine.

[30]  J. Saunders,et al.  A simple procedure for obtaining high‐quality nmr spectra of semiquantitative value from small tissue specimens: cervical biopsies. , 1992, Magnetic resonance in medicine.

[31]  R. Maestro,et al.  p53 over‐expression is an early event in the development of human squamous‐cell carcinoma of the larynx: Genetic and prognostic implications , 1992, International journal of cancer.

[32]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[33]  Adelaide V. Finch,et al.  September , 1867, The Hospital.

[34]  Takesada Mori,et al.  Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma , 2005, Virchows Archiv A.

[35]  M. Dewhirst,et al.  Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[36]  M. Shindo,et al.  Evaluation of Head and Neck Tumor Response to Therapy Using In Vivo 1H MR Spectroscopy: Correlation with Pathology , 2000 .

[37]  Z. Bhujwalla,et al.  Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.

[38]  F. D. Díaz González,et al.  Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. , 1998, Head & neck.

[39]  J. L. Frank,et al.  p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx , 1994, Cancer.

[40]  H. Degani,et al.  Breast Cancer: Spectroscopy and Imaging of Cells and Tumors , 1994 .

[41]  J. Adolfsson,et al.  The TNM system of 1992. Comments from the TNM working group. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. , 1994, Scandinavian journal of urology and nephrology. Supplementum.

[42]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.